Join
Live feed
·
PRReleasevia Quantisnow
Blueprint Medicines Corporation logo
Royalty Pharma plc logo

Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million

ByQuantisnow·Wall Street's wire, on your screen.
BPMC· Blueprint Medicines CorporationRPRX· Royalty Pharma plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BPMC (Blueprint Medicines Corporation), RPRX (Royalty Pharma plc) and more on Quantisnow.